Beyond viral suppression of HIV – the new quality of life frontier
Top Cited Papers
Open Access
- 22 June 2016
- journal article
- opinion
- Published by Springer Science and Business Media LLC in BMC Medicine
- Vol. 14 (1), 1-5
- https://doi.org/10.1186/s12916-016-0640-4
Abstract
In 2016, the World Health Organization (WHO) adopted a new Global Health Sector Strategy on HIV for 2016–2021. It establishes 15 ambitious targets, including the ‘90-90-90’ target calling on health systems to reduce under-diagnosis of HIV, treat a greater number of those diagnosed, and ensure that those being treated achieve viral suppression. The WHO strategy calls for person-centered chronic care for people living with HIV (PLHIV), implicitly acknowledging that viral suppression is not the ultimate goal of treatment. However, it stops short of providing an explicit target for health-related quality of life. It thus fails to take into account the needs of PLHIV who have achieved viral suppression but still must contend with other intense challenges such as serious non-communicable diseases, depression, anxiety, financial stress, and experiences of or apprehension about HIV-related discrimination. We propose adding a ‘fourth 90’ to the testing and treatment target: ensure that 90 % of people with viral load suppression have good health-related quality of life. The new target would expand the continuum-of-services paradigm beyond the existing endpoint of viral suppression. Good health-related quality of life for PLHIV entails attention to two domains: comorbidities and self-perceived quality of life. Health systems everywhere need to become more integrated and more people-centered to successfully meet the needs of virally suppressed PLHIV. By doing so, these systems can better meet the needs of all of their constituents – regardless of HIV status – in an era when many populations worldwide are living much longer with multiple comorbidities.Keywords
This publication has 12 references indexed in Scilit:
- Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapyAIDS, 2016
- Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapyAIDS, 2016
- Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general populationThe Lancet HIV, 2014
- Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort StudyClinical Infectious Diseases, 2014
- Explorations on people centredness in health systemsHealth Policy and Planning, 2014
- Demographics of HIV and agingCurrent Opinion in HIV and AIDS, 2014
- Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected PatientsClinical Infectious Diseases, 2014
- Embedding non-communicable diseases in the post-2015 development agendaThe Lancet, 2013
- Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohortAIDS, 2012
- Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West AfricaAIDS, 2007